Novo Nordisk's Wegovy wins EU backing for reducing heart risks

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Novo Nordisk's blockbuster Wegovy weight loss drug has received backing from the European Union's medical regulator to expand the medicine's use to include reducing the rise of serious heart events in overweight and obese adults.The Danish pharmaceutical giant on Thursday said that the European Medical Agency had adopted a "positive opinion" on the label expansion after reviewing the outcomes of a closely watched SELECT trial, opening t ...